# FDA Inspection 1181074 - Eiger BioPharmaceuticals, Inc. - September 29, 2022

Source: https://www.keypedia.com/records/fda_inspections/eiger-biopharmaceuticals-inc/b8957c4b-dcbd-45c3-b672-ed222d1283e0
Source feed: FDA_Inspections

> FDA Inspection 1181074 for Eiger BioPharmaceuticals, Inc. on September 29, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181074
- Company Name: Eiger BioPharmaceuticals, Inc.
- Inspection Date: 2022-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/eiger-biopharmaceuticals-inc/9b28b6c1-fc02-43ba-ae32-3c486845bede

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c